Loading, Please Wait...
Business Wire IndiaLeading brain-computer interface and healthcare sensor company NeuroSky has created a cost-effective and secure medical monitoring solution that could radically improve remote patient care for people with long term chronic illnesses. The company is working with processor design company ARM, whose technology is in almost all smartphones, to introduce a trusted system that allows the user full control over their data while giving clinicians access to vital information that could help keep patients healthy and out of hospital.
At present, remote healthcare solutions often rely on Bluetooth Link Layer encryption to secure data from a patient monitor to a mobile device before it is sent to an Accountable Care Organization (ACO). This can leave data vulnerable to malware on the mobile device. Other solutions transfer data to the cloud without any kind of user validation before it is sent, leaving data security and privacy in the hands of third party cloud service providers.
NeuroSky has improved this system by using an ARM® processor based medical sensor combined with an ARM TrustZone® enabled Commercial Off The Shelf (“COTS”) mobile device, such as a smartphone, to channel data from the sensor to the patients’ electronic health records. This solution is more secure as data is encrypted on the sensor using ARM mbed™ TLS transport layer security and sent to the phone to be decrypted in a trusted area. The information then has to be validated by the user before data is sent to their ACO.
“Working with readily-available and secure ARM based technology will help to expand the scope of remote health monitoring,” said Stanley Yang, CEO, NeuroSky. “Providing a secure path for data transmission is vital in unlocking remote care at scale and the right systems aren’t yet in place. We believe our solution can change that and making even greater use of cardiovascular and neurological monitoring solutions will have a direct benefit for patients living with serious health conditions.”
The new solution will help ACOs remotely manage patients suffering from conditions such as diabetes or hypertension, and trigger interventions when data anomalies on patients’ medical dashboards are detected. This will help medical device manufacturers create holistic monitoring products for a variety of tasks including heartrate analysis, monitoring glucose and blood oxygen levels, gathering wellness data and sleep tracking.
“The use of trusted off-the-shelf mobile technology in medical sensors can cut billions of dollars a year from the cost of providing remote healthcare services,” said Karthik Ranjan, director, healthcare technology, ARM. “NeuroSky is the first healthcare device company to take this approach in a medical application but these technologies are already widely-used and proven for data sensitive applications such as banking. The healthcare industry is facing a real challenge managing long term chronic illnesses and post-operative care and remotely monitoring patients can lead to improved clinical outcomes as well as saving ACOs money.”
According to Spyglass Consulting Group, a market strategy firm focused on the implications of mobile and wireless technologies within healthcare industry, the solution being offered by NeuroSky has come at the right time.
“Remote monitoring solutions will play a key part in value-based healthcare where medical providers invest in tools to keep large groups of patients healthy,” said Gregg Malkary, managing director, Spyglass Consulting. “This is now encapsulated in law in the US as part of the Affordable Care Act which financially incentivizes doctors and medical facilities to keep patients, especially those with chronic diseases, out of hospital. The new ARM technology based solution from NeuroSky is a natural part this business model as it is designed to be highly secure and cost-effective to deploy at scale.”
NeuroSky is in discussions with healthcare providers to start a technology pilot in 2016.
ARM (LSE: ARM, NASDAQ: ARMH.US) designs technology at the heart of the world's most advanced digital products. We are enabling the development of new markets and transformation of industries and society, invisibly creating opportunity for a globally connected population. Our scalable, energy-efficient processor designs and related technologies deliver intelligence wherever computing happens, ranging from sensors to servers, including smartphones, tablets, digital TVs, enterprise infrastructure and the Internet of Things.
Our innovative technology is licensed by ARM Partners who have shipped more than 75 billion System on Chip (SoCs) containing our intellectual property. Together with our Connected Community, we are breaking down barriers to innovation for developers, designers and engineers, ensuring a fast, reliable route to market for leading electronics companies. Learn more and join the conversation at http://community.arm.com.
NeuroSky technologies enable the most insightful and easy-to-understand health and wellness biometrics for mobile solutions, wearable devices, and service providers. The company’s proprietary, market-leading biosensor technologies provide a foundation for analyzing biometric data in a way that’s never before been practical. NeuroSky-enabled solutions deliver unique insights into body and mind health and wellness that can motivate people to make better lifestyle choices. NeuroSky was founded in 2006, and is headquartered in San Jose, California with offices in Asia and Europe. Learn more at www.neurosky.com.
About Spyglass Consulting Group
Spyglass Consulting Group is a leading market intelligence and strategy firm focused exclusively on the healthcare industry. Based in Menlo Park, CA, the firm provides thought leadership, market coverage, and insights for the most transformative sectors of healthcare IT including point of care computing/ communications, patient engagement, healthcare analytics and remote patient monitoring. Spyglass clients include more than 200 leading technology companies, management consulting firms, healthcare provider organizations, and the investment community.